title: [Influenza infection and pregnancy].
abstract: Pregnant woman have an increased risk of respiratory complications and hospitalization related to influenza. The flu, like any systemic infection, may also be responsible for uterine contractions constituting a threat of miscarriage or premature labor according to gestational age at which it occurs. There is no specific recommendation regarding the management of influenza-like illness in pregnant women, but a nasopharyngeal sample can be performed in the presence of respiratory or general symptoms occurring during an epidemic to search influenza and establish if a specific treatment with oseltamivir (Tamiflu(®)). Surveillance in hospital or intensive care unit may be necessary. Vaccination against influenza provides a satisfactory immunity in pregnant women and reduces the risk of respiratory complications. Transplacental passage of maternal antibody protects newborns who are more likely to have severe influenza infection and because the vaccine cannot be administered before the age of 6 months. The available data show good tolerance influenza vaccination performed during pregnancy. Since 2012, vaccination against seasonal influenza is recommended for pregnant women, whatever the stage of pregnancy at the time of the vaccination campaign.
authors.affiliation: Maternité Port-Royal, université Paris Descartes, DHU risques et grossesse, PRES Sorbonne Paris Cité, service de gynécologie et obstétrique de Port-Royal, groupe hospitalier Cochin Broca Hôtel-Dieu, Assistance publique-Hôpitaux de Paris, 53, avenue de l'Observatoire, 75014 Paris, France(1). Electronic address: olivia.anselem@cch.aphp.fr.
authors.forename: Olivia
authors.initials: O
authors.lastname: Anselem
authors.forename: Daniel
authors.initials: D
authors.lastname: Floret
authors.forename: Vassilis
authors.initials: V
authors.lastname: Tsatsaris
authors.forename: François
authors.initials: F
authors.lastname: Goffinet
authors.forename: Odile
authors.initials: O
authors.lastname: Launay
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007112:Immunity, Maternally-Acquired / Q000276:immunology*; D053118:Influenza A Virus, H1N1 Subtype; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000150:complications / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D011256:Pregnancy Outcome; D014611:Vaccination
chemical_list: D007252:Influenza Vaccines